Cetaphil Daily Facial Moisturizer with suncreen SPF 50 (Galderma Laboratories, L.P.)
Welcome to the PulseAid listing for the Cetaphil Daily Facial Moisturizer with suncreen SPF 50 drug offered from Galderma Laboratories, L.P.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Galderma Laboratories, L.P. |
NON-PROPRIETARY NAME: | octinoxate, octisalate, octocrylene, oxybenzone, titanium dioxide |
SUBSTANCE NAME: | OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2012-01-01 |
END MARKETING DATE: | 0000-00-00 |
Cetaphil Daily Facial Moisturizer with suncreen SPF 50 HUMAN OTC DRUG Details:
Item Description | Cetaphil Daily Facial Moisturizer with suncreen SPF 50 from Galderma Laboratories, L.P. |
LABELER NAME: | Galderma Laboratories, L.P. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 75; 50; 70; 60; 57(mg/mL; mg/mL; mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2012-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0299-4930_bf6ced0f-6062-453c-b024-9c8a3aadc5e1 |
PRODUCT NDC: | 0299-4930 |
APPLICATION NUMBER: | part352 |
Other OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE Pharmaceutical Manufacturers / Labelers: